• Journal of the Korean Society of Radiology
• /
• v.18 no.4
• /
• pp.383-389
• /
• 2024

In this study, we aimed to analyze the probability of secondary cancer occurring in the abdomen, a normal organ, due to photoneutron exposure during intensity-modulated radiotherapy for prostate cancer. The design of the radiation treatment plan for prostate cancer was established as a daily prescription dose of 220 cGy, a total of 35 treatments, and 7700 cGy. The experimental equipment was a True Beam STx (Varian, USA) linear accelerator from Varian. The energy used in the experiment was 15 MV, and the treatment plan was designed so that the photoneutron dose would be generated within the planning target volume (PTV). The radiation treatment plan was an Eclipse System (Varian Ver. 10.0, USA), and the number of irradiation portals was set to 5 to 9. The irradiation angle was designed so that 95% of the prescription dose area was set to 0 to 320°, and the number of beamlets per irradiation portal was set to 100. The optically stimulated luminescence dosimeter used in this study to measure the dose of photoneutrons was designed to measure photoneutron doses by coating ⁶LiCO₃ on a device containing aluminum oxide components. It was studied that there is a minimum of 7.07 to 11 cases per 1,000 people with secondary cancer due to the photoneutron dose to the abdomen during intensity-modulated radiotherapy. In this study, we studied the risk of secondary radiation dose that may occur during intensity-modulated radiotherapy, and we expect that this will be used as meaningful data related to the probabilistic effects of radiation in the future.

• Progress in Medical Physics
• /
• v.25 no.1
• /
• pp.23-30
• /
• 2014

The purpose of this study is to evaluate the developed dose verification program for in vivo dosimetry based on transit dose in radiotherapy. Five intensity modulated radiotherapy (IMRT) plans of lung cancer patients were used in the irradiation of a homogeneous solid water phantom and anthropomorphic phantom. Transit dose distribution was measured using electronic portal imaging device (EPID) and used for the calculation of in vivo dose in patient. The average passing rate compared with treatment planning system based on a gamma index with a 3% dose and a 3 mm distance-to-dose agreement tolerance limit was 95% for the in vivo dose with the homogeneous phantom, but was reduced to 81.8% for the in vivo dose with the anthropomorphic phantom. This feasibility study suggested that transit dose-based in vivo dosimetry can provide information about the actual dose delivery to patients in the treatment room.

• 대한방사선방어학회:학술대회논문집
• /
• 2009.04a
• /
• pp.216-217
• /
• 2009

• Proceedings of the Korean Nuclear Society Conference
• /
• 1995.05a
• /
• pp.931-936
• /
• 1995

서울시 중심부 300m 상공에서 약 22kT의 플루토늄 원폭이 폭발했을 때를 가정하고 폭발시 나오는 초기 방사선에 의한 선량을 계산하였다. 계산을 위하여 몬테칼로 코드인 MCNP4A를 이용하였으며 방사선의 위해도를 알아보기 위하여 선량당량으로 환산 하였다. 계산 결과 가까운 거리에서는 평균자유행로가 짧은 중성자에 의한 선량이 높게 나왔으나 거리가 멀어질수록 감마선에 의한 영향이 더 큰 것으로 나타났다.

• Journal of the Korean Society of Radiology
• /
• v.16 no.3
• /
• pp.211-216
• /
• 2022

In radiation therapy, accurate Quality Assurance (QA) is required to irradiate tumor tissue while minimizing damage to normal tissue. Therefore, a dosimeter that can accurately measure radiation is needed. The purpose of this study is to develop a highly efficient radiation dosimeter with high sensitivity by applying a particle in binder method that can reduce manufacturing costs and simplify processes to perovskite materials that are cheaper and simpler to manufacture. By evaluating the response characteristics to high-energy photon, the applicability of QA dosimeter to radiation therapy was evaluated. As a result of reproducibility evaluation, RSD at 6 MV energy was presented as 1.178% and 15 MV energy was presented as 1.141%. As a result of linearity evaluation according to linear regression analysis, R² values of 0.9999 were presented under each condition of 6 MV and 15 MV energy. It was found that the CsPbBr₃ dosimeter manufactured based on the results of reproducibility and linearity evaluation is highly applicable as a QA dosimeter in the field of therapeutic radiation. The CsPbBr₃ dosimeter manufactured in this study presented more than the standard performance in the evaluation of reproducibility and linearity, and it can be used as a radiotherapy QA dosimeter through improvement.

• Progress in Medical Physics
• /
• v.21 no.3
• /
• pp.298-303
• /
• 2010

The aim of this study was to compare the dose distribution of intensity modulated radiation therapy (IMRT) with 3 dimensional conformal radiation therapy (3DCRT) in prostate cancer. The IMRT plan and the 3DCRT plan used the 9 fields technique, respectively. In IMRT, tumor dose was a total dose of 66 Gy at 2.0 Gy per day, 5 days a week for 5 weeks. All cases were following the dose volume histogram (DVH) constraints. The maximum and minimum tumor dose constraints were 6,700 cGy and 6,500 cGy, respectively. The rectum dose constraints were <35% over 50 Gy. The bladder dose constraints were <35% over 40 Gy. The femur head dose constraints were <15% over 20 Gy. Tumor dose in the 3DCRT were 66 Gy. In IMRT, the maximum dose of PTV was 104.4% and minimum dose was 89.5% for given dose. In 3DCRT, the maximum dose of PTV was 105.3% and minimum dose was 85.5% for given dose. The rectum dose was 34.0% over 50 Gy in IMRT compared with 63.3% in 3DCRT. The bladder dose was 30.1% over 40 Gy in IMRT compared with 30.6% in 3DCRT. The right femur head dose was 9.5% over 20 Gy in IMRT compared with 17.5% in 3DCRT. The left femur head dose was 10.6% over 20 Gy in IMRT compared with 18.3% in 3 DCRT. The dose of critical organs (rectum, bladder, and femur head) in IMRT showed to reduce than dose of 3DCRT. The rectum dose over 50 Gy in IMRT was reduced 29.3% than 3DCRT. The bladder dose over 40 Gy in IMRT was similar to 3DCRT. The femur head dose over 20 Gy in IMRT was reduced about 7~8% than 3DCRT.

• Journal of the Korean Society of Radiology
• /
• v.10 no.6
• /
• pp.375-379
• /
• 2016

A rat is the most common experimental animal used for the realization of the radiation injury model. The certain thickness of rat skin was prepared by peeling off a rat skin. Radiation level was measured by using this rat skin. Also, The schematic of the formula was made that can predict the radiation absorbed dose (RAD) as a function of the thickness of the rat skin. Consequently, we will provide the RAD information in the realization of in-vitro experimental model regarding the rat's skin thickness by applying the formulas. Moreover, the results from this study can be effectively used for the in-vitro experiment of the rat subcutaneous tissue which was exposed to radiation.

• Journal of radiological science and technology
• /
• v.39 no.3
• /
• pp.323-328
• /
• 2016

The spatial dose distribution was measured with ionization chamber as preliminary study to evaluate operator dose and to study dose reduction during neuro-interventional procedures. The zone of operators was divided into four area (45, 135, 225, and 315 degree).We supposed that operator exist on the four area and indicated location of critical organs(eyes, breast, gonad). The spatial doses were measured depending on distance( 80, 100, 120, and 140 cm) and location of critical organs. The spatial doses of area of 225 degree were 114.5 mR/h (eyes location), 143.1 mR/h (breast location) and 147 mR/h (gonad location) in 80 cm. When changed location of x-ray generator, spatial dose increased in $18.1{\pm}10.5%$, averagely. We certified spatial dose in the operator locations, Using the results of this study, It is feasible to protect operator from radiation in neuro-interventional procedures.

• Journal of the Korean Society of Radiology
• /
• v.13 no.3
• /
• pp.399-406
• /
• 2019

This study aims to find geometric parameters that the radiologist can change from time to time to reduce dose in angiography examinations. Depending on the geometric characteristics, the values calculated by effective dose were compared, while filming in fluoroscopy mode and Digital subtraction angiography, respectively. The study found that the lower the dose was in FPS mode, the lower the dose was reduced to 30-40%. Doses according to the X-ray angle were measured highest in AP View and lower as the angle went in the head direction. The greater the FOV, the higher the dose was 1.2-1.6 times, and the closer the distance between the X-ray tube and the table, the greater the dose was about 10%. Source-image intensifier distance (SID) get longer to 100 mm, dose of each fluoroscopy and Digital subtraction angiography increase up to 25-30%. In conclusion, various geometric characteristics in angiography examinations are parameters that can be applied by radiographers as frequently as possible, and appropriate geometric properties can be considered and applied in various situations, resulting in appropriate dose reduction.

• Radiation Oncology Journal
• /
• v.20 no.3
• /
• pp.228-236
• /
• 2002

Purpose : Although high-dose-rate (HDR) brachytherapy regimens have been practiced with a variety of modalities and various degrees of success, few studies on the subject have been conducted. The purpose of this study was to compare the results of local control and late complication rate according to different HDR brachytherapy fractionation regimens in uterine cervical cancer patients. Methods and Materials : From November 1992 to March 1998, 224 patients with uterine conical cancer were treated with external beam irradiation and HDR brachytherapy. In external pelvic radiation therapy, the radiation dose was $45\~54\;Gy$ (median dose 54 Gy) with daily fraction size 1.8 Gy, five times per week. In HDR brachytherapy, 122 patients (Group A) were treated with three times weekly with 3 Gy to line-A (isodose line of 2 cm radius from source) and 102 patients (Group B) underwent the HDR brachytherapy twice weekly with 4 or 4.5 Gy to line-A after external beam irradiation. Iridium-192 was used as the source of HDR brachytherapy. Late complication was assessed from grade 1 to 5 using the RTOG morbidity grading system. Results : The local control rate (LCR) at 5 years was $80\%$ in group A and $84\%$ in group B (p=0.4523). In the patients treated with radiation therapy alone, LCR at 5 years was $60.9\%$ in group A and $76.9\%$ in group B (p=0.2557). In post-operative radiation therapy patients, LCR at 5 years was $92.6\%$ In group A and $91.6\%$ in group B (p=0.8867). The incidence of late complication was $18\%$ (22 patients) and $29.4\%$ (30 patients), of bladder complication was $9.8\%$ (12 patients) and $14.7\%$ (15 patients), and of rectal complication was $9.8\%$ (12 patients) and $21.6\%$ (22 patients), in group A and B, respectively. Lower fraction sized HDR brachytherapy was associated with decrease in late complication (p=0.0405) (rectal complication, p=0.0147; bladder complication, p=0.115). The same result was observed in postoperative radiation therapy patients (p=0.0860) and radiation only treated patients (0=0.0370). Conclusion : For radiation only treated patients, a greater number of itemized studies on the proper fraction size of HDR brachytherapy, with consideration for stages and prognostic factors, are required. In postoperative radiation therapy, the fraction size of HDR brachytherapy did not have much effect on local control, yet the incidence of late complication increased with the elevation in fraction size. We suggest that HDR brachytherapy three times weekly with 3 Gy could be an alternative method of therapy.